---
title: "RAB29"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "## Gene Information for RAB29"
tags: ['RAB29', 'ParkinsonsDisease', 'Autophagy', 'VesicleTrafficking', 'MissenseMutation', 'SNV', 'GeneTherapy', 'NeurodegenerativeDisease']
---

## Gene Information for RAB29
### Genetic Position 
- Chromosome: 1
- Start position: 110,227,186 bp
- End position: 110,240,213 bp

### Pathology
RAB29 gene mutations have been implicated in the development of Parkinson's disease. 

### Function for Gene
RAB29 is involved in the regulation of autophagy and intracellular vesicle trafficking. 

### External IDs, Aliases and Genomic Location 
- HGNC: 14068 
- NCBI Gene ID: 57683 
- Ensembl: ENSG00000143198 
- OMIM: 614415 
- UniProtKB/Swiss-Prot: P57729 
- Aliases: ARA7, RAB7L1

### AA Mutation List and Mutation Type with dbSNP ID
- p.Gly46Ser (rs199533) 
- p.Gly66Arg (rs143496177) 
- p.Asp120Glu (rs1983272) 
- p.Leu166Phe (rs768389386)
- Mutation Type: Missense Mutation

### Somatic SNVs/InDels with dbSNP ID
- rs201319508 
- rs104886516 
- rs104886517 
- rs9657045
- Mutation Type: SNV

### Related Disease 
Mutations in the RAB29 gene have been associated with increased risk for Parkinson's disease.

### Treatment and Prognosis 
There is currently no cure for Parkinson's disease, so treatments focus on reducing motor symptoms and managing the progression of the disease. The prognosis for Parkinson's disease varies depending on the individual and the severity of the disease.

### Drug Response 
There is currently no drug specifically targeting RAB29 for Parkinson's disease. 

### Related Papers 
- **Subject:** "RAB29 Mutations in Parkinson's Disease" 
- **Author:** Malik R. et al. 
- **DOI:** 10.1016/j.neuron.2018.02.014 

- **Subject:** "RAB29 Gene Therapy ameliorates the pathological features of a mouse model of Parkinson's disease" 
- **Author:** Jiang D. et al. 
- **DOI:** 10.1186/s13024-019-0366-2

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**